Termination of Registration of a Class of Security Under Section 13 and 15(d) (15-15d)
15 Agosto 2016 - 7:05AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 15
CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934.
|
|
|
|
Commission File Number
|
333-137920
|
|
BioCube, Inc.
|
(Exact name of registrant as specified in its charter)
|
|
7320 North Dreamy Draw Drive, Suite 120, Phoenix, AZ 85020
|
(Address, including zip code, and telephone number, including area code, of registrants principal executive offices)
|
|
Common Stock
|
(Title of each class of securities covered by this Form)
|
|
None
|
(Titles of all other classes of securities for which a duty to file reports under section 13(a) or 15(d) remains)
|
|
Please place an X in the box(es) to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports:
|
|
Rule 12g-4(a)(1)
|
X
.
|
Rule 12g-4(a)(2)
|
.
|
Rule 12h-3(b)(1)(i)
|
.
|
Rule 12h-3(b)(1)(ii)
|
.
|
Rule 15d-6
|
.
|
Rule 15d-22(b)
|
.
|
|
|
Approximate number of holders of record as of the certification or notice date:
|
93
|
Pursuant to the requirements of the Securities Exchange Act of 1934 BioCube, Inc. has caused this certification/notice to be signed on its behalf by the undersigned duly authorized person.
|
|
|
|
|
Date:
|
August 11, 2016
|
|
By:
|
/s/ Paul Lisak
|
|
|
|
|
Name Paul Lisak
|
|
|
|
|
Its: Chief Executive Officer
|
BioCube (CE) (USOTC:BICB)
Gráfico Histórico do Ativo
De Nov 2024 até Dez 2024
BioCube (CE) (USOTC:BICB)
Gráfico Histórico do Ativo
De Dez 2023 até Dez 2024
Notícias em tempo-real sobre BioCube Inc (CE) da OTCMarkets bolsa de valores: 0 artigos recentes
Mais Notícias de Biocube, Inc.